Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS

Open access

Abstract

Calcium-channel blockers (CCBs) constitute a diverse group of compounds but are often referred to as a single homogeneous class of drug and the clinical responses indiscriminately summarized. Even within the dihydropyridine subgroup, there are significant differences in formulations, pharmacokinetics, durations of action and their effects on blood pressure, heart rate, end organs and the sympathetic nervous system. Amlodipine and nifedipine in the gastrointestinal therapeutic system (GITS) formulation are the most studied of the once-daily CCBs. Amlodipine has an inherently long pharmacokinetic half-life, whereas, in contrast, nifedipine has an inherently short half-life but in the GITS formulation the sophisticated delivery system allows for once-daily dosing. This article is derived from a systematic review of the published literature in hypertensive patients. The following search terms in three main databases (MEDLINE, Embase, Science Citation Index) from 1990 to 2011 were utilized: amlodipine, nifedipine, sympathetic nervous system, sympathetic response, sympathetic nerve activity, noradrenaline, norepinephrine and heart rate. More than 1500 articles were then screened to derive the relevant analysis. As markers of sympathetic nervous system activation, studies of plasma norepinephrine concentrations, power spectral analysis, muscle sympathetic nerve activity and norepinephrine spillover were reviewed. Overall, each drug lowered blood pressure in hypertensive patients in association with only small changes in heart rate (i.e. <1 beat/min). Plasma norepinephrine concentrations, as the most widely reported marker of sympathetic nervous system activity, showed greater increases in patients treated with amlodipine than with nifedipine GITS. The evidence indicates that both these once-daily dihydropyridine CCBs lower blood pressure effectively with minimal effects on heart rate. There are small differences between the drugs in the extent to which each activates the sympathetic nervous system with an overall non-significant trend in favour of nifedipine GITS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/08037051.2012.690615

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The effects of amlodipine and nifedipine gastrointestinal therapeutic system (GITS) on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and plasma norepinephrine (NE) when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Tables I and II for all the studies cited.
Figure 1 The effects of amlodipine and nifedipine gastrointestinal therapeutic system (GITS) on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and plasma norepinephrine (NE) when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Tables I and II for all the studies cited.CC BY · PubMed Central
Figure 2 The effects of amlodipine on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and muscle sympathetic nerve activity (MSA) when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Table III for all the studies cited.
Figure 2 The effects of amlodipine on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and muscle sympathetic nerve activity (MSA) when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Table III for all the studies cited.CC BY · PubMed Central
Figure 3 The effects of amlodipine on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), low frequency (LF), high frequency (HF) and the ratio of low to high frequency (LF/HF) of the power spectrum when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Table IV for all the studies cited.
Figure 3 The effects of amlodipine on systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), low frequency (LF), high frequency (HF) and the ratio of low to high frequency (LF/HF) of the power spectrum when the drug is given over weeks of treatment. This figure is based on the mean percentage changes from Table IV for all the studies cited.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 8

  1. Leenen FHH, 2002, Can J Cardiol, 18, 1285
  2. Malamani GD, 1999, J Hypertens, 17, S134
  3. Ruzicka M, 2007, Am J Hypertens, 20, 1202
  4. Larochelle P, 2008, J Hypertens, 26, S462
  5. Sanjuliani AF, 2002, J Hypertens, 20, S206
  6. Calhoun DA, 1997, Journal of Investigative Medicine, 70
  7. Dodt C, 2000, Hypertens, 18, S29
  8. Lucini D, 1999, J Hypertens, 17, S253

Cited by

See all 64

Metadata

Authors
Toal, C. B., Meredith, P. A., & Elliott, H. L.
Affiliations
  • University of Toronto (CA)
  • University of Glasgow (GB)
  • University of Strathclyde (GB)
Corresponding author
Toal, Corey B.
Venue
Blood Pressure
Published
2012-07
Volume
21
Issue
sup1
Pages
3-10
ISSN
  • 0803-7051 (ISSN-L)
  • 1651-1999
OpenAlex
W2098125802
Cited by
64
References
60
Citations by year
2026: 5 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 10 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 1
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • Blood Pressure (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Bayer
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
amlodipine, nifedipine GITS, dihydropyridine calcium channel blockers, hypertension, sympathetic activity, plasma norepinephrine, muscle sympathetic nerve activity, norepinephrine spillover, heart rate, blood pressure reduction, once-daily dosing, sustained-release formulation
MeSH terms
Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Consensus Statements as Topic, Geriatrics, Humans, Hypertension, United States, Randomized Controlled Trials as Topic, Practice Guidelines as Topic, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS. https://app.cochat.ai/papers/10.3109/08037051.2012.690615
The paper
Toal, C. B., Meredith, P. A., & Elliott, H. L. (2012). Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS. Blood Pressure. https://doi.org/10.3109/08037051.2012.690615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.